23andMe states that if it's involved in a bankruptcy or sale, customers' personal data may also be sold or transferred. It also provides a relatively straightforward way for customers to delete their data and request that their genetic samples be destroyed.
The Trump administration wants to spend more federal dollars replicating medical research. A key question will be which studies get repeated and, with limited resources, at what expense. Many findings can't be replicated — a problem scientists say needs to be addressed. But it could also consume increasingly scarce resources as the administration cuts spending and freezes federal grants.
The Trump administration is shuttering HHS' long COVID office as part of its reorganization, according to an internal email seen by POLITICO. The email was sent Monday by Ian Simon, the head of the Office of Long COVID Research and Practice. It said the closing is part of HHS's reorganization.
Susan Monarez has previously held several prominent positions within the U.S. government. She served as deputy director of the Advanced Research Projects Agency for Health, where she led initiatives in AI and health technology. She has also held roles at the Department of Homeland Security and the White House Office of Science and Technology Policy. This nomination is notable as Monarez would be the first CDC director to require Senate confirmation, following a law change in 2022.
Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward.
Thomas Payne, HCA Healthcare's national medical director of robotics, explains how the largest U.S. health system is vetting a new crop of market entrants.